Literature DB >> 17007558

Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers.

Cécile M Ronckers1, Alice J Sigurdson, Marilyn Stovall, Susan A Smith, Ann C Mertens, Yan Liu, Sue Hammond, Charles E Land, Joseph P Neglia, Sarah S Donaldson, Anna T Meadows, Charles A Sklar, Leslie L Robison, Peter D Inskip.   

Abstract

Radiation exposure at a young age is a strong risk factor for thyroid cancer. We conducted a nested case-control study of 69 thyroid cancer cases and 265 controls from a cohort of 14,054 childhood cancer survivors to evaluate the shape of the radiation dose-response relationship, in particular at high doses, and to assess modification of the radiation effects by patient and treatment characteristics. We considered several types of statistical models to estimate the excess relative risk (ERR), mainly guided by radiobiological models. A two-parameter model with a term linear in dose and a negative exponential in dose squared provided the best parsimonious description with an ERR of 1.3 per gray (95% confidence interval 0.4-4.1) at doses below 6 Gy and a relative decrease in ERR of 0.2% per unit dose squared with increasing dose, that is, decreases in the ERR/Gy of 53% at 20 Gy and 95% at 40 Gy. Further analyses using spline models suggested that the significant nonlinearity at high doses was characterized most appropriately as a true downturn rather than a flattening of the dose-response curve. We found no statistically significant modification of the dose-response relationship by patient characteristics; however, the linear parameter (i.e., the ERR/ Gy at doses less than 6 Gy) did decrease consistently and linearly with increasing age at childhood cancer diagnosis, from 4.45 for 0-1-year-olds to 0.48 for 15-20-year-olds. In summary, we applied models derived from radiobiology to describe the radiation dose-response curve for thyroid cancer in an epidemiological study and found convincing evidence for a downturn in risk at high doses.

Entities:  

Mesh:

Year:  2006        PMID: 17007558     DOI: 10.1667/RR3605.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   3.372


  44 in total

1.  Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy.

Authors:  Jonas D Fontenot; Charles Bloch; David Followill; Uwe Titt; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation.

Authors:  Igor Shuryak; Philip Hahnfeldt; Lynn Hlatky; Rainer K Sachs; David J Brenner
Journal:  Radiat Environ Biophys       Date:  2009-06-05       Impact factor: 1.925

3.  Thirty-Five Years of Thyroid Cancer Experience in a Paediatric Population: Incidence Trends in Lithuania between 1980 and 2014.

Authors:  Rima Bėrontienė; Edita Jašinskienė; Rosita Kiudelienė; Gintaras Kuprionis; Jurgita Makštienė; Raminta Macaitytė; Dalia Marčiulionytė; Lina Poškienė; Agnė Šemetaitė; Vygantas Šidlauskas; Raimondas Valickas; Rimantas Žalinkevičius; Rasa Verkauskienė
Journal:  Eur Thyroid J       Date:  2016-11-09

Review 4.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Gary L Francis; Steven G Waguespack; Andrew J Bauer; Peter Angelos; Salvatore Benvenga; Janete M Cerutti; Catherine A Dinauer; Jill Hamilton; Ian D Hay; Markus Luster; Marguerite T Parisi; Marianna Rachmiel; Geoffrey B Thompson; Shunichi Yamashita
Journal:  Thyroid       Date:  2015-07       Impact factor: 6.568

5.  Second cancer after total-body irradiation (TBI) in childhood.

Authors:  Pascal Pommier; Marie Pierre Sunyach; Caroline Pasteuris; Didier Frappaz; Christian Carrie
Journal:  Strahlenther Onkol       Date:  2009-08       Impact factor: 3.621

Review 6.  Secondary malignancies across the age spectrum.

Authors:  Andrea K Ng; Lisa B Kenney; Ethel S Gilbert; Lois B Travis
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

Review 7.  Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy.

Authors:  Harald Paganetti
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

8.  Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.

Authors:  Rui Zhang; Rebecca M Howell; Annelise Giebeler; Phillip J Taddei; Anita Mahajan; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2013-01-16       Impact factor: 3.609

9.  Size, number, and distribution of thyroid nodules and the risk of malignancy in radiation-exposed patients who underwent surgery.

Authors:  Dan V Mihailescu; Arthur B Schneider
Journal:  J Clin Endocrinol Metab       Date:  2008-04-01       Impact factor: 5.958

10.  Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today.

Authors:  M Jacob Adams; Ann Dozier; Roy E Shore; Steven E Lipshultz; Ronald G Schwartz; Louis S Constine; Thomas A Pearson; Marilyn Stovall; Paul Winters; Susan G Fisher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.